Document Detail

Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension.
MedLine Citation:
PMID:  23130108     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Patients affected by pulmonary arterial hypertension (PAH) show a typical pattern of abnormalities on cardiopulmonary exercise testing (CPET). However, CPET is not routinely used as a screening method. We discuss a patient with hereditary PAH in whom CPET revealed onset of disease. Furthermore, we show that the abnormalities observed can improve in part by PAH-specific treatment.
Pia Trip; Anton Vonk-Noordegraaf; Harm Jan Bogaard
Related Documents :
15033968 - Chronic intermittent hypoxia and incremental cycling exercise independently depress mus...
2220568 - Evaluation of methods for destruction of some alkylating agents.
1723328 - Dialysis of plasma soluble lipofuscins in patients with end-stage renal failure.
10087238 - Effects of acute prolonged exposure to high-altitude hypoxia on exercise-induced breath...
2006618 - Right ventricular systolic function during exercise with and without significant corona...
10097378 - Sudden death in right ventricular dysplasia with minimal gross abnormalities.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pulmonary circulation     Volume:  2     ISSN:  2045-8940     ISO Abbreviation:  Pulm Circ     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-11-06     Completed Date:  2012-12-12     Revised Date:  2014-03-18    
Medline Journal Info:
Nlm Unique ID:  101557243     Medline TA:  Pulm Circ     Country:  India    
Other Details:
Languages:  eng     Pagination:  387-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle ...
Next Document:  Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension.